Patent Application
20200000569
The present disclosure relates to a puncture apparatus, and more particularly to an insertion instrument, which includes a vaginal insertion portion (or vaginal stabilizer) and a urethral insertion portion (or urethral stabilizer).
In a patient suffering from urinary incontinence, for example, stress urinary incontinence, urine leakage (involuntary urination) occurs due to an abnormal pressure exerted during a normal exercise or by, for example, laughing, coughing, or sneezing. This can be attributable, for example, to loosening of a pelvic floor muscle, which is a muscle for supporting a urethra, caused by childbirth.
For treatment of urinary incontinence, surgical therapy can be effective. For example, a tape-shaped implant called a “sling” can be placed indwelling in the body to support the urethra (for example, U.S. Pat. No. 6,911,003). In order to put a sling indwelling in the body, an operator incises a vagina with a surgical knife, dissects a biological tissue (living body tissue) between the urethra and the vagina, and provides communication between the exfoliated biological tissue site and an exterior through an obturator foramen by using a puncture needle. Then, in such a state, the sling is placed indwelling in the body.
If a vaginal wall is once incised, however, there can be a fear that the sling might be exposed to an inside of the vagina via a wound caused by the incision. There can also be a fear that complications might occur which can be caused by an infection via the wound. In addition, since the vaginal wall is incised, an invasiveness of the procedure can be rather great and patient burden can be relatively heavy. In addition, there can be a fear that the urethra or the like can be damaged by a surgical knife in the course of the procedure by the operator, and there can be a fear that the operator himself might damage his fingertip by the surgical knife.
Further, when an implant is placed indwelling in a living body, there may arise a case, depending on a length of the implant, where part of the implant can located near the living body surface, such that the patient may experience pain.
A puncture apparatus is disclosed by which the burden exerted on a patient can be relatively alleviated when an implant is put indwelling in the living body.
A vaginal insertion portion is disclosed, the vaginal insertion portion comprising: a base portion; a proximal holding portion located on a proximal side of the base portion; and a suction portion located on a distal side of the proximal holding portion.
A puncture apparatus is disclosed comprising: an insertion portion that is insertable into a living body, the insertion portion comprising: a urethral insertion portion having an inflatable and deflatable balloon on a distal end of the urethral insertion portion, and a plurality of suction holes at an intermediate portion of the urethral insertion portion; and a vaginal insertion portion, the vaginal insertion portion having a base portion, a proximal holding portion located on a proximal side of the base portion, and a suction portion located on distal side of the proximal holding portion; and a puncture needle that punctures living body tissues between the urethral insertion portion and the vaginal insertion portion in a state in which the insertion portion is inserted into the living body.
A method is disclosed for suctioning a tissue adjacent a first lumen of a living body, comprising: inserting an insertion portion comprising a base portion, a proximal holding portion located on a proximal side of the base portion, and a suction portion located on a distal side of the proximal holding portion into the first lumen; and applying a suction to the suction portion so that the insertion portion fixes the tissue facing the suction portion through the first lumen.
In accordance with an exemplary embodiment, a puncture apparatus 1 as shown in
The puncture apparatus 1 can include a frame (support unit) 2, a puncture member 3, a urethral insertion member 4, a vaginal insertion member 5, and an operating member 7. In the puncture apparatus 1, the urethral insertion member 4 and the vaginal insertion member 5 constitute an insertion instrument 6. The operating member 7 is a member operating the puncture member 3.
Such an operating member 7, as shown in
In accordance with an exemplary embodiment, the insertion portion 71 can be circular in cross-sectional shape. Alternatively, the insertion portion 71 may be flat-shaped in cross section. The flat shape is not limited. Examples of the flat shape applicable here can include not only ellipses but also rounded-cornered rhombuses, rounded-cornered rectangles (flat shapes), and spindle-like shapes enlarged (enlarged in diameter) at a central portion as compared with both end portions of the insertion portion being flat-shaped in cross section.
In accordance with an exemplary embodiment, such an operating member 7 can be configured to be higher than the puncture member 3 in rigidity. The material constituting the operating member 7 is not limited. Examples of the material applicable here can include various metallic materials such as stainless steels, aluminum, aluminum alloys, titanium, and titanium alloys.
The puncture member 3 is a member puncturing a living body. Such a puncture member 3 can include, for example, an elongate sheath (medical tube) (not shown), and a needle body provided at a distal end of the sheath as described in U.S. Patent Publication Nos. 2015/0080644, which is incorporated herein by reference in its entirety. For example, the sheath main body (not shown) can be configured by use of an elongate tube, which is open at a distal end and a proximal end of the elongate tube. Such a sheath main body can have an internal space in which an implant main body can be inserted. In addition, the sheath main body can be in an arcuate curved shape, and can have a flat cross-sectional shape.
In accordance with an exemplary embodiment, for example, the puncture member 3 passes through the living body from one groin to the other groin. A sheath for introducing the sling into the living body can be connected at the distal end of the puncture member 3 which is protruded out of the living body. The sheath can be placed into the living body by moving in the opposite direction to the direction of introducing the puncture member 3.
The frame 2 turnably holds the operating member 7 on which the puncture member 3 is mounted. In addition, the frame 2 detachably fixes the insertion instrument 6. The frame 2 has a function of determining a puncture route for the needle body 35 at the time of puncturing of a biological tissue by the puncture member 3. For example, the frame 2 can determine a positional relationship between the puncture member 3, the urethral insertion member 4, and the vaginal insertion member 5 in such a manner that when a biological tissue is punctured by the puncture member 3, the needle body 35 can pass between the urethral insertion member 4 and the vaginal insertion member 5 without colliding against or striking any of the insertion members 4 and 5.
As shown in
The bearing portion 21 can be located on the proximal end in the puncture apparatus 1. The guide portion 22 can be located on the distal end in the puncture apparatus 1, and is disposed opposite to the bearing portion 21. As shown in
When a rotating operation is applied to the operating member 7 as shown in
The apparatus 1 can also include an adjustment knob 710 (
The interlock portion 23 can interlock the shaft portion 21 and the guide portion 22 to each other. In addition, the interlock portion 23 can be in the shape of a bar. The interlock portion 23 can also function as a grasping portion, allowing an operator to use the puncture apparatus 1 while grasping the interlock portion 23.
As shown in
In addition, the support portion 60 can include a support portion 40, which is possessed by the urethral insertion member 4 and supports the urethral insertion portion 41, and a support portion 50, which is possessed by the vaginal insertion member 5 and supports the vaginal insertion portion 51. In the insertion instrument 6, the urethral insertion member 4 and the vaginal insertion member 5 can be freely detachable by way of the support portions 40 and 50, respectively. The urethral insertion member 4 and the vaginal insertion member 5 will be sequentially described below.
As shown in
The vaginal insertion member 5 can include the elongated vaginal insertion member (first insertion portion) 51 whose portion from a distal end to an intermediate portion of insertion member 51 is inserted into a vagina, and the support portion 50 supporting the vaginal insertion portion 51. In the following, for convenience of description as shown in
The vaginal insertion portion 51 can be elongated. In accordance with an exemplary embodiment, the vaginal insertion portion 511 is spaced from the urethral insertion portion 411 on the distal end. In accordance with an exemplary embodiment, the vaginal insertion portion 511 can be parallel or inclined relative to the urethral insertion portion 411. In the mounted state, for example, the puncture apparatus 1 can be held stably onto the patient, and burden on the patient can be mitigated. The inclination angle of the insertion portion 511 relative to the insertion portion 411 is not limited, for example, the inclination angle can be about 0 to 45 degrees, and more preferably about 0 to 30 degrees, or alternatively, most preferably about 0 degrees as shown in
As shown in
In accordance with an exemplary embodiment, a distal portion of the vaginal insertion portion 51 includes a distal end 650, a pair of angled sidewalls 652 extending from the distal end 650 and an angled upper surface 654 extending towards the distal portion 622 and the suction portion 610.
The vaginal insertion portion 51 can also include a suction port 612 on the proximal portion, which is communication with the suction portion 610 of the vaginal insertion portion 51. The suction port 612 can be connected to a suction device, such as a pump, and when the suction device is operated in a state wherein the vaginal insertion portion 51 is inserted in the vagina, a vaginal wall can be sucked and fixed onto the suction portion 610.
In accordance with an exemplary embodiment, a distance from the proximal holding portion 620 to the distal holding portion 622 can be, for example, about 5 mm to 30 mm, and more preferably about 8 mm to 18 mm. For example, the suction portion 620 can have a length of about 5 mm to 30 mm, and more preferably about 10 to 20 mm, and a width of about 5 mm to 60 mm, and more preferably about 25 mm to 50 mm. In accordance with an exemplary embodiment, the needle pass portion 630 preferably has a height of 3 mm to 20 mm, a width of 7 mm to 62 mm, and a length of 5 mm to 30 mm.
The vaginal insertion portion 51 of can have a substantially constant width and a somewhat rounded and angled distal portion. For example, a length of the vaginal insertion portion 51 is not limited, and can be, for example, about 20 to 100 mm, more preferably about 30 to 60 mm. A width of the vaginal insertion portion 51 is not limited, and can be, for example, about 10 to 60 mm, more preferably about 30 to 50 mm. In addition, the thickness of the vaginal insertion portion 51 is not limited, and can be, for example, about 5 to 35 mm, more preferably about 15 to 25 mm. Set to have such length, width, and thickness, the vaginal insertion portion 51 is suited in shape and size to ordinary vaginas. Therefore, stability of the puncture apparatus 1 in the mounted state can be enhanced, and burden on the patient can be relatively alleviated.
The material constituting the vaginal insertion member 5 is not limited. Examples of the material applicable here include various metallic materials such as stainless steels, aluminum, aluminum alloys, titanium, titanium alloys, etc. and various resin materials, like the examples of the material for the urethral insertion member 4.
The urethral insertion portion 41 can be in the shape of a tube with its distal end rounded. In addition, the insertion portion 411 is provided at its distal portion with an inflatable and deflatable balloon 42 and a urine drain portion (not shown). The balloon 42 can function as a restriction portion restricting the position in an axial direction of the urethral insertion member 4 in the inside of the urethra. For example, when the puncture apparatus 1 is used, the balloon 42 is inflated after inserted into a patient's bladder. Then, with the balloon 42 caught on a bladder neck, the position of the urethral insertion member 4 relative to the bladder and the urethra is fixed. In accordance with an exemplary embodiment, the urine drain portion can be used for draining urine present inside the bladder.
The balloon 42 extends through the inside of the urethral insertion portion 41, to be connected to a balloon port (not shown) provided at a proximal portion of the urethral insertion portion 41. A balloon-inflating instrument such as a syringe can be connected to the balloon port (not shown). When a working fluid (a liquid such as physiological salt solution, or a gas or the like) is supplied from the balloon-inflating instrument into the balloon 42, the balloon 42 is inflated. When the working fluid is drawn out of the balloon 42 by the balloon-inflating instrument, the balloon 42 is deflated. The balloon 42 and the urine drain portion (not shown) can be configured by use of a double lumen, for example.
In addition, the insertion portion 411 can be formed with a plurality of suction holes 44 at an intermediate portion of the insertion portion 411. The plurality of suction holes 44 can be laid out over the whole range in the circumferential direction of the urethral insertion portion 41. Each of the suction holes 44 can be connected to a suction port 45 provided at a proximal portion of the urethral insertion portion 41, via the inside of the urethral insertion portion 41. A suction device such as a pump can be connected to the suction port (not shown). When the suction device is operated in a state wherein the urethral insertion portion 41 is inserted in the urethra, a urethral wall can be sucked and fixed onto the urethral insertion portion 41. When the urethral insertion portion 41 is pushed in toward the distal end (toward the inside of the body) under this condition, the urethra is also pushed in together with the urethral insertion portion 41. As a result, for example, the bladder and the urethra can be shifted to such a position as not to overlap with a puncture route for the puncture member 3, whereby the puncture route for the puncture member 3 can be secured. Therefore, puncturing by the puncture member 3 can be carried out relatively accurately and safely. It is to be noted that the number of the suction holes 44 is not limited, for example, the number may be one. In addition, layout of the suction holes 44 is not limited, for example, the suction holes 44 may be formed in only a part of the range in the circumferential direction of the urethral insertion portion 41.
In addition, at the boundary portion between the insertion portion 411 and the non-insertion portion 412, a marker (not shown) can be provided to check the depth of insertion of the urethral insertion portion 41 into the urethra. When the urethral insertion portion 41 is inserted in the urethra and the balloon 42 is located inside the bladder, the marker is located at the urethral orifice, which permits relatively easy checking of the depth of insertion of the insertion portion 411 into the urethra. The marker is necessary only to be externally visible, and can be composed essentially of, for example, a colored portion, a recessed and projected portion, or the like. In accordance with an exemplary embodiment, a graduation with indications of distance from the distal end of the urethral insertion portion 41 may be provided, in place of the marker.
The length of the insertion portion 411 is not limited, and may be set, as necessary, according to the length of the urethra and the shape of the bladder of the patient, or the like. The length of the insertion portion 411 can be, for example, about 50 to 100 mm, in view of the fact that the length of a female urethra is generally about 30 to 50 mm.
The length of the non-insertion portion 412 (the spacing between the urethral orifice and the support portion 40) is not limited. The length can be, for example, not more than about 100 mm, preferably in the range of about 20 to 50 mm. By such a setting, the length of the non-insertion portion 412 can be made appropriate, which can provide relatively enhanced operability. For example, if the length of the non-insertion portion 412 exceeds the just-mentioned upper limit, the center of gravity of the puncture apparatus 1 would, depending on the configuration of the frame 2 or the like factors, be largely deviated from the patient, possibly leading to a lowered stability of the puncture apparatus 1 in the mounted state.
The material constituting the urethral insertion member 4 is not limited. Examples of the material applicable here include various metallic materials such as stainless steels, aluminum, aluminum alloys, titanium, titanium alloys, etc. and various resin materials.
In addition, as shown in
In addition, while the case where the puncture apparatus 1 is applied to an implant for treatment of female urinary incontinence has been described in the above exemplary embodiments, this is not restrictive of the use of the implant.
Examples of which the present disclosure is applicable can include pelvic floor diseases inclusive of excretory disorders (urinary urgency, frequent urination, urinary incontinence, fecal incontinence, urinary retention, dysuria, etc.), pelvic organ prolapse, vesicovaginal fistula, urethrovaginal fistula, and pelvic pain, which would be attendant on weakening of the group of pelvic floor muscles. The pelvic organ prolapse include such diseases as cystocele, enterocele, rectocele, and hysterocele, or such diseases as anterior vaginal prolapse, posterior vaginal prolapse, vaginal apical prolapse, and vaginal vault prolapse, which are denominations based on classification of the vaginal wall part being prolapsed.
In addition, examples of overactive tissue can include the bladder, vagina, uterus, and bowels. Examples of lessactive tissue can include bones, muscles, fascias, and ligaments. For example, in relation to the pelvic floor diseases, examples of the lessactive tissue include obturator fascia, coccygeus fascia, cardinal ligament, uterosacral ligament, and sacrospinous ligament.
Examples of the procedure for interlocking an overactive tissue in the pelvic floor disorder with the lessactive tissue, can include a retropubic sling surgery, a transobturator sling surgery (Transobturator Sling Surgery, Transobturator Tape; TOT), a tension-free vaginal mesh (Tension-free Vaginal Mesh; TVM) surgery, a uterosacral ligament suspension (Uterosacral Ligament Suspension; USLS) surgery, an iliococcygeus fascia fixation surgery, and a coccygeus fascia fixation surgery.
The detailed description above describes a puncture apparatus. The disclosure is not limited, however, to the precise exemplary embodiments and variations described. Various changes, modifications and equivalents can effected by one skilled in the art without departing from the spirit and scope of the disclosure as defined in the accompanying claims. It is expressly intended that all such changes, modifications, and equivalents which fall within the scope of the claims are embraced by the claims.
This application claims priority to U.S. Provisional Patent Application No. 62/192,225 filed on Jul. 14, 2015, the entire content of which is incorporated herein by reference.
| Number | Date | Country | |
|---|---|---|---|
| 20170014218 A1 | Jan 2017 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62192225 | Jul 2015 | US |
